UBE2V2 Antibody

UBE2V2

1 alpha 25 dihydroxyvitamin D3 inducible antibody; DDVit 1 antibody; DDVIT1 antibody; EDAF-1 antibody; EDAF1 antibody; EDPF-1 antibody; EDPF1 antibody; Enterocyte differentiation associated factor EDAF 1 antibody; Enterocyte differentiation promoting factor antibody; Enterocyte differentiation-associated factor 1 antibody; Enterocyte differentiation-promoting factor 1 antibody; Methyl methanesulfonate sensitive 2 antibody; MMS 2 antibody; MMS2 antibody; MMS2 homolog antibody; UB2V2_HUMAN antibody; UBE2V 2 antibody; UBE2V2 antibody; Ubiquitin conjugating enzyme E2 variant 2 antibody; Ubiquitin conjugating enzyme E2v2 antibody; Ubiquitin-conjugating enzyme E2 variant 2 antibody; UEV 2 antibody; UEV2 antibody; Vitamin D3 inducible protein antibody; Vitamin D3-inducible protein antibody

Recombinant Human Ubiquitin-conjugating enzyme E2 variant 2 protein (2-145AA)

Has no ubiquitin ligase activity on its own. The UBE2V2/UBE2N heterodimer catalyzes the synthesis of non-canonical poly-ubiquitin chains that are linked through 'Lys-63'. This type of poly-ubiquitination does not lead to protein degradation by the proteasome. Mediates transcriptional activation of target genes. Plays a role in the control of progress through the cell cycle and differentiation. Plays a role in the error-free DNA repair pathway and contributes to the survival of cells after DNA damage.

>95%, Protein G purified

Epigenetics and Nuclear Signaling

Recombinant Human Ubiquitin-conjugating enzyme E2 variant 2 protein (2-145AA)